Human mesenchymal stem cells (hMSCs) target osteosarcoma and promote its growth and pulmonary metastasis

Cancer Letters

Volumn 281, Issue 1, 2009, Pages 32-41

  Xu, Wen ting ^a   Bian, Zhen yu ^a   Fan, Qi ming ^a   Li, Gang ^b   Tang, Ting ting ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

CCL5; Mesenchymal stem cells; Metastasis; Osteosarcoma; SDF 1

Indexed keywords

RANTES; STROMAL CELL DERIVED FACTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; MALE; MESENCHYMAL STEM CELL; METASTASIS POTENTIAL; MOUSE; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN FUNCTION; TUMOR PROMOTION;

ANIMALS; BONE NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINE CCL5; CHEMOKINE CXCL12; CULTURE MEDIA, CONDITIONED; DISEASE PROGRESSION; HUMANS; LUNG NEOPLASMS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED BALB C; MICE, NUDE; OSTEOSARCOMA;

ANIMALIA; MUS MUSCULUS;

EID: 67349110806     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.02.022     Document Type: Article

References (45)

1. Murphey M.D., Robbin M.R., McRae G.A., Flemming D.J., Temple H.T., and Kransdorf M.J. The many faces of osteosarcoma. Radiographics 17 (1997) 1205-1231
2. Meyers P.A., and Gorlick R. Osteosarcoma. Pediatr. Clin. N. Am. 44 (1997) 973-989
3. Link M.P., Goorin A.M., Miser A.W., Green A.A., Pratt C.B., Belasco J.B., Pritchard J., Malpas J.S., Baker A.R., Kirkpatrick J.A., et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. New. Engl J. Med. 314 (1986) 1600-1606
4. Friedenstein A.J., Chailakhyan R.K., Latsinik N.V., Panasyuk A.F., and Keiliss-Borok I.V. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues, cloning in vitro and retransplantation in vivo. Transplantation 17 (1974) 331-340
5. Austin T.W., Solar G.P., Ziegler F.C., Liem L., and Matthews W. A role for the Wnt gene family in hematopoiesis: expansion of multilineage progenitor cells. Blood 89 (1997) 3624-3635
6. Dexter T.M., Spooncer E., Schofield R., Lord B.I., and Simmons P. Haemopoietic stem cells and the problem of self-renewal. Blood Cells 10 (1984) 315-339
7. Van Den Berg D.J., Sharma A.K., Bruno E., and Hoffman R. Role of members of the Wnt gene family in human hematopoiesis. Blood 92 (1998) 3189-3202
8. Willert K., Brown J.D., Danenberg E., Duncan A.W., Weissman I.L., Reya T., Yates III J.R., and Nusse R. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423 (2003) 448-452
9. Pittenger M.F., and Martin B.J. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ. Res. 95 (2004) 9-20
10. Studeny M., Marini F.C., Dembinski J.L., Zompetta C., Cabreira-Hansen M., Bekele B.N., Champlin R.E., and Andreeff M. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J. Natl. Cancer Inst. 96 (2004) 1593-1603
11. Nakamizo A., Marini F., Amano T., Khan A., Studeny M., Gumin J., Chen J., Hentschel S., Vecil G., Dembinski J., Andreeff M., and Lang F.F. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res. 65 (2005) 3307-3318
12. Nakamura K., Ito Y., Kawano Y., Kurozumi K., Kobune M., Tsuda H., Bizen A., Honmou O., Niitsu Y., and Hamada H. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther. 11 (2004) 1155-1164
13. Komarova S., Kawakami Y., Stoff-Khalili M.A., Curiel D.T., and Pereboeva L. Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses. Mol. Cancer Ther. 5 (2006) 755-766
14. Studeny M., Marini F.C., Champlin R.E., Zompetta C., Fidler I.J., and Andreeff M. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res. 62 (2002) 3603-3608
15. Hung S.C., Deng W.P., Yang W.K., Liu R.S., Lee C.C., Su T.C., Lin R.J., Yang D.M., Chang C.W., Chen W.H., Wei H.J., and Gelovani J.G. Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging. Clin. Cancer Res. 11 (2005) 7749-7756
16. Khakoo A.Y., Pati S., Anderson S.A., Reid W., Elshal M.F., Rovira II, Nguyen A.T., Malide D., Combs C.A., Hall G., Zhang J., Raffeld M., Rogers T.B., Stetler-Stevenson W., Frank J.A., Reitz M., and Finkel T. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J. Exp. Med. 203 (2006) 1235-1247
17. Karnoub A.E., Dash A.B., Vo A.P., Sullivan A., Brooks M.W., Bell G.W., Richardson A.L., Polyak K., Tubo R., and Weinberg R.A. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449 (2007) 557-563
18. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
19. Manes S., Mira E., Colomer R., Montero S., Real L.M., Gomez-Mouton C., Jimenez-Baranda S., Garzon A., Lacalle R.A., Harshman K., Ruiz A., and Martinez A.C. CCR5 expression influences the progression of human breast cancer in a p53-dependent manner. J. Exp. Med. 198 (2003) 1381-1389
20. Taichman R.S., Cooper C., Keller E.T., Pienta K.J., Taichman N.S., and McCauley L.K. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res. 62 (2002) 1832-1837
21. Zlotnik A., and Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 12 (2000) 121-127
22. Bleul C.C., Fuhlbrigge R.C., Casasnovas J.M., Aiuti A., and Springer T.A. A highly efficacious lymphocyte chemoattractant stromal cell-derived factor 1 (SDF-1). J. Exp. Med. 184 (1996) 1101-1109
23. Gupta S.K., Lysko P.G., Pillarisetti K., Ohlstein E., and Stadel J.M. Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines. J. Biol. Chem. 273 (1998) 4282-4287
24. Robinson S.C., Scott K.A., Wilson J.L., Thompson R.G., Proudfoot A.E., and Balkwill F.R. A chemokine receptor antagonist inhibits experimental breast tumor growth. Cancer Res. 63 (2003) 8360-8365
25. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., and Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
26. Li D., Dai K., and Tang T. Effects of dextran on proliferation and osteogenic differentiation of human bone marrow-derived mesenchymal stromal cells. Cytotherapy 10 (2008) 587-596
27. Luu H.H., Kang Q., Park J.K., Si W., Luo Q., Jiang W., Yin H., Montag A.G., Simon M.A., Peabody T.D., Haydon R.C., Rinker-Schaeffer C.W., and He T.C. An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis. Clin. Exp. Metastas. 22 (2005) 319-329
28. Corcione A., Ottonello L., Tortolina G., Facchetti P., Airoldi I., Guglielmino R., Dadati P., Truini M., Sozzani S., Dallegri F., and Pistoia V. Stromal cell-derived factor-1 as a chemoattractant for follicular center lymphoma B cells. J. Natl. Cancer Inst. 92 (2000) 628-635
29. Koshiba T., Hosotani R., Miyamoto Y., Ida J., Tsuji S., Nakajima S., Kawaguchi M., Kobayashi H., Doi R., Hori T., Fujii N., and Imamura M. Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin. Cancer Res. 6 (2000) 3530-3535
30. Libura J., Drukala J., Majka M., Tomescu O., Navenot J.M., Kucia M., Marquez L., Peiper S.C., Barr F.G., Janowska-Wieczorek A., and Ratajczak M.Z. CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion. Blood 100 (2002) 2597-2606
31. Campbell J.J., Hedrick J., Zlotnik A., Siani M.A., Thompson D.A., and Butcher E.C. Chemokines and the arrest of lymphocytes rolling under flow conditions. Science 279 (1998) 381-384
32. Bachelder R.E., Wendt M.A., and Mercurio A.M. Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res. 62 (2002) 7203-7206
33. Fernandis A.Z., Prasad A., Band H., Klosel R., and Ganju R.K. Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells. Oncogene 23 (2004) 157-167
34. Kijima T., Maulik G., Ma P.C., Tibaldi E.V., Turner R.E., Rollins B., Sattler M., Johnson B.E., and Salgia R. Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells. Cancer Res 62 (2002) 6304-6311
35. Ohira S., Itatsu K., Sasaki M., Harada K., Sato Y., Zen Y., Ishikawa A., Oda K., Nagasaka T., Nimura Y., and Nakanuma Y. Local balance of transforming growth factor-beta1 secreted from cholangiocarcinoma cells and stromal-derived factor-1 secreted from stromal fibroblasts is a factor involved in invasion of cholangiocarcinoma. Pathol. Int. 56 (2006) 381-389
36. Saur D., Seidler B., Schneider G., Algul H., Beck R., Senekowitsch-Schmidtke R., Schwaiger M., and Schmid R.M. CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer. Gastroenterology 129 (2005) 1237-1250
37. Strieter R.M. Chemokines: not just leukocyte chemoattractants in the promotion of cancer. Nat. Immunol. 2 (2001) 285-286
38. Aboody K.S., Brown A., Rainov N.G., Bower K.A., Liu S., Yang W., Small J.E., Herrlinger U., Ourednik V., Black P.M., Breakefield X.O., and Snyder E.Y. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc. Natl. Acad. Sci. USA 97 (2000) 12846-12851
39. De Palma M., Venneri M.A., Roca C., and Naldini L. Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat. Med. 9 (2003) 789-795
40. Relf M., LeJeune S., Scott P.A., Fox S., Smith K., Leek R., Moghaddam A., Whitehouse R., Bicknell R., and Harris A.L. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res. 57 (1997) 963-969
41. Reyes M., Dudek A., Jahagirdar B., Koodie L., Marker P.H., and Verfaillie C.M. Origin of endothelial progenitors in human postnatal bone marrow. J. Clin. Invest. 109 (2002) 337-346
42. John A.E., Berlin A.A., and Lukacs N.W. Respiratory syncytial virus-induced CCL5/RANTES contributes to exacerbation of allergic airway inflammation. Eur. J. Immunol. 33 (2003) 1677-1685
43. Schall T.J., Jongstra J., Dyer B.J., Jorgensen J., Clayberger C., Davis M.M., and Krensky A.M. A human T cell-specific molecule is a member of a new gene family. J. Immunol. 141 (1988) 1018-1025
44. Adler E.P., Lemken C.A., Katchen N.S., and Kurt R.A. A dual role for tumor-derived chemokine RANTES (CCL5). Immunol. Lett. 90 (2003) 187-194
45. Kyriakou C., Rabin N., Pizzey A., Nathwani A., and Yong K. Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model. Haematologica 93 (2008) 1457-1465